REGULATORY INTELLIGENCE·Recall
FDA Class II Recall: Thea Pharma's Betimol Ophthalmic Solution Faces Sterility and Container Integrity Issues
Thea Pharma Inc. initiated a Class II recall for Betimol (timolol ophthalmic solution) due to sterility, volume, and container closure issues. This event underscores critical quality control vulnerabilities in sterile manufacturing, demanding heightened vigilance from procurement, regulatory, and supply chain leaders to mitigate patient safety risks and ensure product integrity across the pharmaceutical industry.
90-Day Activity